{
  "study_id": "OPTIMAL, CTONG-0802",
  "study_title": "Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)",
  "table_name": "Figure 2",
  "table_title": "Forest plot of OS by clinical characteristics (intent-to-treat population).",
  "description": "This table represents a forest plot of overall survival by clinical characteristics for the intent-to-treat population. The 'n' column represents the total number of patients in each subgroup across both treatment arms.",
  "footnotes": [
    "CI, confidence interval; ECOG; Eastern Cooperative Oncology Group; EGFR, epidermal growth factor receptor; HR, hazard ratio; PS, performance status."
  ],
  "groups": [
    {
      "name": "Erlotinib",
      "n": 82,
      "type": "intervention"
    },
    {
      "name": "Gemcitabine plus carboplatin",
      "n": 72,
      "type": "intervention"
    },
    {
      "name": "Total",
      "n": 154,
      "type": "summary"
    }
  ],
  "characteristics": [
    {
      "original_label": "Overall",
      "standardized_name": "Overall Population",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "numeric_single",
          "value": 154.0,
          "raw_string": "154",
          "n_for_value": 154
        }
      ],
      "comparison_statistics": {
        "statistic_type": "Hazard Ratio",
        "statistic_value": 1.19,
        "p_value": 0.2663,
        "notes": "95% CI 0.83-1.71. P-value is from Log-rank test shown in Figure 1.",
        "raw_string": "1.19 (0.83-1.71)"
      }
    },
    {
      "original_label": "Stage",
      "standardized_name": "Disease Stage",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "IV",
      "standardized_name": "Disease Stage",
      "category": "IV",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Stage",
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "numeric_single",
          "value": 138.0,
          "raw_string": "138",
          "n_for_value": 154
        }
      ]
    },
    {
      "original_label": "IIIB",
      "standardized_name": "Disease Stage",
      "category": "IIIB",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Stage",
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "numeric_single",
          "value": 16.0,
          "raw_string": "16",
          "n_for_value": 154
        }
      ]
    },
    {
      "original_label": "Sex",
      "standardized_name": "Sex",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Male",
      "standardized_name": "Sex",
      "category": "Male",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sex",
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "numeric_single",
          "value": 63.0,
          "raw_string": "63",
          "n_for_value": 154
        }
      ]
    },
    {
      "original_label": "Female",
      "standardized_name": "Sex",
      "category": "Female",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sex",
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "numeric_single",
          "value": 91.0,
          "raw_string": "91",
          "n_for_value": 154
        }
      ]
    },
    {
      "original_label": "Age",
      "standardized_name": "Age",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "<65 years",
      "standardized_name": "Age",
      "unit": "years",
      "category": "<65",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age",
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "numeric_single",
          "value": 116.0,
          "raw_string": "116",
          "n_for_value": 154
        }
      ]
    },
    {
      "original_label": "≥65 years",
      "standardized_name": "Age",
      "unit": "years",
      "category": "≥65",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age",
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "numeric_single",
          "value": 38.0,
          "raw_string": "38",
          "n_for_value": 154
        }
      ]
    },
    {
      "original_label": "ECOG PS",
      "standardized_name": "ECOG Performance Status",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "0-1",
      "standardized_name": "ECOG Performance Status",
      "category": "0-1",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "ECOG PS",
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "numeric_single",
          "value": 144.0,
          "raw_string": "144",
          "n_for_value": 154
        }
      ]
    },
    {
      "original_label": "2",
      "standardized_name": "ECOG Performance Status",
      "category": "2",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "ECOG PS",
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "numeric_single",
          "value": 10.0,
          "raw_string": "10",
          "n_for_value": 154
        }
      ]
    },
    {
      "original_label": "Smoking status",
      "standardized_name": "Smoking Status",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Present or former smoker",
      "standardized_name": "Smoking Status",
      "category": "Current or Former Smoker",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Smoking status",
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "numeric_single",
          "value": 45.0,
          "raw_string": "45",
          "n_for_value": 154
        }
      ]
    },
    {
      "original_label": "Non-smoker",
      "standardized_name": "Smoking Status",
      "category": "Non-smoker",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Smoking status",
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "numeric_single",
          "value": 109.0,
          "raw_string": "109",
          "n_for_value": 154
        }
      ]
    },
    {
      "original_label": "Histology",
      "standardized_name": "Histology",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Adenocarcinoma",
      "standardized_name": "Histology",
      "category": "Adenocarcinoma",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histology",
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "numeric_single",
          "value": 134.0,
          "raw_string": "134",
          "n_for_value": 154
        }
      ]
    },
    {
      "original_label": "Non-adenocarcinoma",
      "standardized_name": "Histology",
      "category": "Non-adenocarcinoma",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histology",
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "numeric_single",
          "value": 20.0,
          "raw_string": "20",
          "n_for_value": 154
        }
      ]
    },
    {
      "original_label": "EGFR mutation type",
      "standardized_name": "EGFR Mutation Type",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Exon 19 mutation",
      "standardized_name": "EGFR Mutation Type",
      "category": "Exon 19 Deletion",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "EGFR mutation type",
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "numeric_single",
          "value": 82.0,
          "raw_string": "82",
          "n_for_value": 154
        }
      ]
    },
    {
      "original_label": "Exon 21 mutation",
      "standardized_name": "EGFR Mutation Type",
      "category": "Exon 21 L858R",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "EGFR mutation type",
      "group_data": [
        {
          "group_name": "Erlotinib",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Gemcitabine plus carboplatin",
          "data_type": "text",
          "text_value": "Data not provided",
          "raw_string": ""
        },
        {
          "group_name": "Total",
          "data_type": "numeric_single",
          "value": 72.0,
          "raw_string": "72",
          "n_for_value": 154
        }
      ]
    }
  ]
}